System for delivering sequential components

Information

  • Patent Grant
  • 7909165
  • Patent Number
    7,909,165
  • Date Filed
    Friday, March 16, 2007
    17 years ago
  • Date Issued
    Tuesday, March 22, 2011
    13 years ago
Abstract
System 10 delivers specified medication(s) 10M of a specified dosage in a specified sequence (see FIG. 1A). Flexible cover lamina 12C is pressed into selective engagement base lamina 12B defining a series of sequential storage units 10X and 10Y and 10Z with frangible seal 14F (no hatching) and destruct seal 14D (double hatching). Sealed medication chamber 16M is proximate the destruct seal within each storage unit. Chamber access region 16R is proximate the frangible seal within each storage unit. Diagonal chamber seal 14S (single hatching) extends across each storage unit. Breachable bubble 16B is positioned within each chamber access region and expands under applied pressure towards the frangible seal of the storage unit (see FIGS. 1A and 1B). The expansion separates the opposed laminae until the bubble produces perimeter breach 12P (see FIG. 1C) in the frangible seal. Flexible peel flap 14C is formed by the flexible cover lamina along the breached frangible seal as the bubble breaches. The flap is peeled away from the base lamina by the user, parting the chamber seal to open the medication chamber providing access to the medication stored therein.
Description
TECHNICAL FIELD

This invention relates to delivering sequential components, and more particularly delivering the components in an easy to open storage unit.


BACKGROUND

Traditionally, patients and other pill-takers along with their caretakers execute a weekly pill-fill ritual. They gather their stock jars and bottles other repositories of their medication stock, and load a seven-day receptacle. Each bin of the receptacle holds all the medications for the day, or for a particular time period. The pill-fill requires the pill takers or caretaker to know where the pill supplies are stored, and which medications are to be taken, and at what time. For many pill-takers, the print on the medication bottle is too small for them to read. The caps and closure devices can be difficult to remove. Transferring the small pills to the proper small bin container can be a trial.


SUMMARY

It is therefore an object of this invention to provide a series of sequential storage units for presenting small components such as parts or medication in an easy to open storage unit. A breachable bubble on the storage unit is compressed causing a edge breach with peel flaps that can be pulled back to open the storage unit. Self-assembly products may require a dozen assembly steps involving hundreds of small parts of many sizes such as bolts, nuts, washers, screws, brackets, and small tools. Each step entails a specified group of parts. The assembler must locate and use each part in a specified sequence for orderly assembly of the product.


It is another object of this invention to provide such a series of sequential storage units which are loaded with medication by qualified people under controlled conditions. The storage units may be automatically loaded at major hospitals and mail-order pharmaceutical warehouses. Orders are filled by trained clerks and skilled technicians using reliable computers and extensive data bases.


It is a further object of this invention to provide such a series of sequential storage units for sequentially presenting medications for sequential delivery. As each storage unit is presented and the medications disbursed, it is intuitively clear which of the remaining storage unit is next.


Briefly, these and other objects of the present invention are accomplished by providing a system for delivering specified components of a specified quantity in a specified sequence. A base lamina and a flexible cover lamina are pressed into opposed selective engagement defining a series of sequential storage units. A perimeter seal formed around each storage unit has a frangible seal portion and a destruct seal portion. A sealed medication chamber within each storage unit proximate the destruct seal stores a dosage of the medication. A chamber access region within each storage unit is proximate the frangible seal portion for accessing the medication chamber. A chamber seal formed by the selective engagement of the opposed laminae, extends across each storage unit between the medication chamber and the chamber access region. A breachable bubble is formed within each chamber access region by the opposed laminae during the selective engagement. The bubble is between the frangible seal portion and the chamber seal. The bubble expands under applied pressure towards the frangible seal portion of the storage unit. The expansion separates the opposed laminae forming the bubble, until the bubble produces a perimeter breach in the frangible seal portion. A flexible peel flap is formed by the flexible cover lamina along the breached frangible seal portion as the bubble breaches. The flap may be peeled away from the base lamina detaching the chamber seal to open the medication chamber providing delivery of the medication stored therein.





BRIEF DESCRIPTION OF THE DRAWINGS

Further objects and advantages of the sequence of storage units and the operation of the breachable bubble will become apparent from the following detailed description and drawings (not drawn to scale) in which:



FIG. 1A is a fragmentary top view of a series of storage units 10X and 10Y and 10Z showing medication chamber 16M containing medications 10M;



FIG. 1B is a fragmentary sectional view taken generally along reference line IB-IB of FIG. 1A prior to the breaching of bubble 16B;



FIG. 1C is a fragmentary side view of the storage units after to the breaching of bubble 16B;



FIG. 2 is a fragmentary top view of delivery sheet 20 of storage units 20U;



FIG. 3 is a top view of delivery strip 30 of storage units 30U showing catch tray 32T;



FIG. 4 is a side view of medication dispenser 48D for supporting delivery spool 48 containing a roll of sequential storage units 40U; and



FIG. 5 is a front view of a calendar medication delivery system 50 having rigid base 52B.





The first digit of each reference numeral in the above figures indicates the figure in which an element or feature is most prominently shown. The second digit indicates related elements or features, and a final letter (when used) indicates a sub-portion of an element or feature.


REFERENCE NUMERALS IN DRAWINGS

The table below lists the reference numerals employed in the figures, and identifies the element designated by each numeral.














10 Delivery system










10K
Corner



10M
Medication(s)



10X
Sequential Storage Unit



10Y
Sequential Storage Unit



10Z
Sequential Storage Unit



10XY
Boundary



10YZ
Boundary



12B
Base Lamina



12C
Cover Lamina



12P
Perimeter Breach



14B
Base Flexible peel flap



14C
Cover Flexible peel flap



14D
Destruct Seal Portion (left and right)



14F
Frangible Seal Portion (left and right)



14S
Diagonal Chamber Seal



14XY
Tear-Away Cut Lines



14YZ
Tear-Away Cut Lines



16B
Breachable Bubble



16M
Sealed Medication Chamber



16R
Chamber Access Region







20 Delivery Sheet










20K
Corner



20U
Sequential Storage Unit



24P
Tear-Away Perforations 24P



26R
Chamber Access Region







30 Delivery Strip










30L
Medical Data Label



30U
Sequential Storage Unit



32B
Base Lamina



32C
Cover Lamina



32T
Catch Tray



34F
Frangible Seal Portions



36M
Medication Chamber



36R
Chamber Access Region



40M
Medications



40U
Sequential Storage Unit







48 Delivery Spool










48D
Medication Dispenser



48M
Inner Mooring End



48T
Outer Terminal End







50 Calendar Matrix










50A
am Storage Unit



50P
pm Storage Unit



50U
Storage Units



52B
Rigid Base Lamina










General Embodiment—(FIG. 1ABC)

System 10 delivers specified components in specified quantities such as medication(s) 10M of a specified dosage, in a specified sequence (see FIG. 1A). Flexible cover lamina 12C is pressed into selective engagement base lamina 12B (see FIG. 1B). The selective engagement of the opposed laminae defines a series of sequential storage units 10X and 10Y and 10Z. A perimeter seal is formed around each storage unit by the pressed selective engagement. The perimeter seal has a frangible seal portion and a destruct seal portion. The perimeter seal for storage unit 10Y has frangible seal portion 14F (no hatching) and destruct seal portion 14D (double hatching). A frangible seal formed by two laminae heat pressed together can be separated without harmful damage to either lamina, simply by pulling the laminae apart. A destruct seal, however, cannot be separated without damage to one or both of the laminae.


Sealed medication chamber 16M for storing a dosage of the medication, is proximate the destruct seal within each storage unit. Chamber access region 16R for accessing the medication chamber, is proximate the frangible seal portion within each storage unit. Diagonal chamber seal 14S (single hatching) formed by the pressed selective engagement of the opposed laminae, extends across each storage unit between the medication chamber and the chamber access region. Breachable bubble 16B is positioned within each chamber access region between the frangible seal portion and the chamber seal. The bubble is formed by a volume gas, such as ambient air, trapped between the opposed laminae during the selective engagement. The bubble expands under applied pressure towards the frangible seal of the storage unit (see FIGS. 1A and 1B). The expansion separates the opposed laminae forming the bubble, until the bubble produces perimeter breach 12P (see FIG. 1C) in the frangible seal portion. Flexible peel flap 14C is formed by the flexible cover lamina along the breached frangible seal as the bubble breaches. The flap is peeled away from the base lamina by the user, parting the chamber seal to open the medication chamber providing access to the medication stored therein. The user may be the patient who is under medication, or the caretaker who administers the medication or other healthcare professional.


The bubble is expandable to open the package by external pressure applied by a consumer. For small bubbles, the consumer may simply pinch a bubble or bubbles between his thumb and forefinger. Slightly larger bubbles may require thumb-to-thumb pressure. The very young and older, infirm consumers may push downward on the bubble against a flat surface with a smooth aide such as a spoon. The consumer may direct the bubble expansion outward towards edge of the package by applying the pressure along the inward side of the bubble proximate point “X”. Inward expansion of the bubble is limited because the applied pressure keeps the opposed laminae pressed together in sealing engagement along the inward side. Therefore, expansion due to the directed pressure is primarily outward urging the bubble outward towards the edge of the package, as indicated by the large outward arrow. The outward bubble expansion progressively separates the opposed laminae forming the outer seal, along a moving separation frontier. The frontier moves across the outer seal until the frontier reaches the edge of the package, where the bubble breaches creating edge breach.


The destruct seals are stronger than the frangible seals due to a higher temperature and/or pressure and/or dwell-time during the pressing stage of seal formation. That is, the destruct seals are fused together more than the frangible seals. Preferably the chamber seal has a strength greater than the weak frangible seal but not as great as the strong destruct seal. The chamber seal is stronger than the weak frangible seal so that the chamber seal will not separate during breaching of the bubble which produces the perimeter breach. The chamber seal is weaker than the strong destruct seal so that the medication chamber can be pulled opened after breach of the frangible seal.


U.S. Pat. No. 6,726,364 issued on Apr. 27, 2004 to the present inventor shows a breaching bubble which provides opposed peel flaps along a perimeter breach. The flaps are peeled back by the user to open a chamber and present a product. The subject matter of U.S. Pat. No. 6,726,364 is hereby incorporated by reference in its entirety into this disclosure.


Diagonal Chamber Seal—FIG. 1A

The chamber seal within each storage unit may extend diagonally across the storage unit between the medication chamber and the chamber access region. Diagonal chamber seal 14S (see FIG. 1A) defines triangular shapes for medication chamber 16M and chamber access region 16R. The triangular medication chamber has destruct seals 14D (left and right) along the two legs, and diagonal chamber seal 14S across the hypotenuse. The triangular chamber access region has frangible seals 14F (left and right) along the two legs, and chamber seal 14S across the hypotenuse. The chamber seal is about 1.4 times as long as a single leg of the frangible seal. When the chamber seal is parted, the user has maximum finger or hand access to the medications in the medication chamber. Other non-diagonal configurations may be employed. FIG. 2 shows a non-symmetrical embodiment in which chamber access region 26R is limited to a small area in corner 20K. FIG. 3 shows a straight embodiment in which medication chamber 36M is larger than chamber access region 36R.


The boundaries between the sequential storage units has both a destruct seal and a frangible seal. Boundary 10XY between unit 10X and 10Y has frangible seal 14F (right) of unit 10X, adjacent to destruct seal 14D (left) of unit 10Y. Likewise, boundary 10YZ between unit 10Y and 10Z has frangible seal 14F (right) of unit by, adjacent to destruct seal 14D (left) of unit 10Z. The frangible seal must peel away as a storage unit is opened, leaving the adjacent destruct seal intact for maintaining the integrity of the adjacent storage unit. Cover lamina 12C has tear-away cut line 14XY along boundary 10XY, and tear-away cut line 14YZ along boundary 10YZ. The cut lines are between the frangible seal and the destruct seal to permit the cover lamina of one storage unit to pull-away from the cover lamina of the adjacent storage unit. This tear-away cut line is preferable a depth controlled laser cut through the cover lamina, which terminates at the base lamina.


The delivery system may have a flexible cover lamina with a rigid base lamina, which provides a single flexible peel flap. The user holds the rigid base down and pulls the flexible flap away to expose the medication. Alternatively, base lamina 12B may also be flexible forming flexible peel flap 14B opposed to peel flap 14C formed by flexible cover lamina 12C (see FIG. 1C). The pair of peel flaps facilitates pulling apart the chamber seal.


The peel flaps may be positioned at a corner of each storage unit. Corner 10K permits ease of gripping the peel flaps by the user (see FIG. 1C) and peeling them back unsealing frangible seal 14F (left and right). Alternatively, the peel flap may be positioned in the middle between two corners (see FIG. 3).


Strip Embodiment—FIG. 3

The base lamina and cover lamina may be a strip for sequential presentation of the series of sequential storage units in a strip array. Base lamina strip 32B (see FIG. 3) may be wider than cover lamina strip 32C and extend beyond perimeter frangible seal portion 34F of the cover lamina. This extension provides tray 32T for catching the stored medications as they are delivered. The catch tray may have a raised edge berm for retaining the medication on the tray.


The strip of opposed laminae may be wound onto delivery spool 48 (see FIG. 4) with inner mooring end 48M and outer terminal end 48T, for sequential presentation of the strip of sequential storage units from the terminal end. Medication dispenser 48D may be provided for supporting the delivery spool and the storage units. Medications 40M may be vacuum packed within the sealed medication chambers on the strip of storage units. Removing the air from the medication chamber reduces the shipping volume and spool size requirements. Even a slight vacuum locks the medications in place during shipment and handling, preventing them from grinding against one another. Alternatively, an inert gas may be provided within the sealed medication chamber for preserving the medication. A nitrogen flush introduced just before sealing the medication chamber displaces the ambient oxygen.


The cover lamina may be transparent permitting visible identification of the medication. Medications are frequently known to the user or caretaker only by color or size or shape. The lamina may be color coded to indicate the period of day for taking the medications. For example, pink may indicate morning, yellow may indicate noon, and blue may indicate evening. Alternatively, the cover lamina and the base lamina may be opaque for preventing UV and other photo damage.


Row and Column Embodiments—FIG. 2 and FIG. 5

The series of sequential storage units may be a matrix of rows and columns across a sheet of opposed laminae. The entire inventory of medication can be seen at a glance. A series of tear-away perforations 24P (see FIG. 2) traverse the matrix between adjacent storage units 20U, permitting presentation of a single storage unit. A medication storage unit may be torn-away from the matrix and distributed individually. Alternatively, each of the sequential storage units may be firmly secured to the preceding storage unit and to the succeeding storage unit (see FIG. 3) along the strip of opposed laminae. The empty storage units remain on the strip after delivery, along with the full storage units containing forgotten medication, as a record of compliance.


Calendar matrix 50 of sequential storage units 50U may have a plurality of horizontal rows corresponding to the weeks of a particular month. The matrix may also have seven vertical columns corresponding to the seven days of each week. The user can easily locate and identify the medication for each day. The calendar day may be divided into am and pm storage units 50A and SOP as shown for Tuesday the 4th in FIG. 5. The base lamina for the calendar matrix may be sufficiently rigid to be self standing and function as a stand-up display of the matrix of storage units and of the medications sequentially stored therein.


Medical Data

Medical data relating to the medication may be associated with each storage unit. The name and dosage of the medication may be listed along with the schedule (date and time of day for taking). Important side effects and emergency numbers may be listed. The patient's name and age, and the name of the doctor or caretaker may be provided. The medical data may be printed directly on the lamina, or on label 30L later affixed to the lamina (see FIG. 3), or inserted into the medication chamber or chamber access region. The basic information may be included in a quick scan format such as bar code. More extensive data, such as medical history may be included in a suitable mega format such as toned digital data.


INDUSTRIAL APPLICABILITY

It will be apparent to those skilled in the art that the objects of this invention have been achieved as described hereinbefore. Various changes may be made in the structure and embodiments shown herein without departing from the concept of the invention. Further, features of embodiments shown in various figures may be employed in combination with embodiments shown in other figures. Therefore, the scope of the invention is to be determined by the terminology of the following claims and the legal equivalents thereof.

Claims
  • 1. System for delivering specified components in specified quantities in a specified sequence, comprising: a base lamina;a flexible cover lamina opposed to the base lamina;a perimeter seal sealing the cover lamina to the base lamina, forming a series of sequential storage units, the perimeter seal having a frangible seal portion and a destruct seal portion, the destruct seal portion formed such that the base lamina and the cover lamina cannot be separated at the destruct seal portion without damage to at least one of the base lamina and the cover lamina;a chamber seal extending across each of the series of sequential storage units and further sealing the cover lamina to the base lamina;a component chamber within each of the series of sequential storage units defined by the chamber seal and the destruct seal portion;a chamber access region within each of the series of sequential storage units defined by the chamber seal and the frangible seal portion;a breachable bubble within each chamber access region and formed by the cover lamina and the base lamina;wherein expansion of the breachable bubble due to directed pressure causes progressive separation of the cover lamina and the base lamina at the frangible seal portion until the breachable bubble produces a perimeter breach in the frangible seal portion; anda flexible peel flap formed by the flexible cover lamina along the breached frangible seal portion as the breachable bubble breaches, which flap is peeled away from the base lamina at the chamber seal, breaching the chamber seal to open the component chamber and provide delivery of the components stored therein.
  • 2. The system of claim 1, wherein the flexible peel flap is positioned at a corner of each of the series of sequential storage units.
  • 3. The system of claim 1, wherein the chamber seal within each of the series of sequential storage units extends diagonally across the storage unit between the component chamber and the chamber access region.
  • 4. The system of claim 1, wherein the base lamina is also flexible forming a peel flap opposed to the peel flap formed by the flexible cover lamina.
  • 5. The system of claim 1, wherein the base lamina and the cover lamina are strips forming a strip for sequential presentation of the series of sequential storage units.
  • 6. The system of claim 5, further comprising a series of tear-away perforations traversing the strips of base lamina and cover lamina between each of the sequential storage units, to permit presentation of a single storage unit.
  • 7. The system of claim 5, wherein the base lamina strip is wider than the cover lamina strip and extends beyond the perimeter frangible seals of the cover lamina to provide a tray for catching the stored components as they are delivered.
  • 8. The system of claim 5, wherein the strips of base lamina and cover lamina wound onto a delivery spool, and have an inner mooring end and an outer terminal end for sequential presentation of the strip of sequential storage units from the terminal end.
  • 9. The system of claim 8, further comprising a dispenser for supporting the delivery spool during the sequential presentation of the strip of sequential storage units.
  • 10. The system of claim 1, wherein each of the series of sequential storage units is firmly secured to the preceding storage unit and to the succeeding storage unit along the strips of base lamina and cover lamina.
  • 11. The system of claim 1, wherein the cover lamina is transparent permitting visible identification of the components.
  • 12. The system of claim 1, wherein the cover lamina and the base lamina are opaque.
  • 13. The system of claim 1, further comprising component data associated with each storage unit and related to the components stored therein.
  • 14. The system of claim 1, wherein the specified components are specified medications of specified dosages delivered in a specified sequence.
  • 15. The system of claim 14, wherein the series of sequential storage units is a matrix of rows and columns across the opposed laminae.
  • 16. The system of claim 15, wherein the base lamina is sufficiently rigid to be self standing and function as a stand-up display of the matrix of storage units and of the medications sequentially stored therein.
  • 17. The system of claim 15, wherein the matrix of rows and columns of the sequential storage units has a plurality of horizontal rows corresponding to the weeks of a particular month, and has seven vertical columns corresponding to the seven days of each week.
  • 18. The system of claim 14, wherein the medications are vacuum packed within the component chamber.
  • 19. The system of claim 14, further comprising an inert gas within the component chamber for preserving the medication.
Parent Case Info

This application claims the benefit of provisional application Ser. No. 60/790,482, filed Apr. 10, 2006.

US Referenced Citations (90)
Number Name Date Kind
3074544 Bollmeier et al. Jan 1963 A
3189227 Hobbs et al. Jun 1965 A
3256981 Kurtz Jun 1966 A
3294227 Schneider et al. Dec 1966 A
3301390 Via, Jr. Jan 1967 A
3405797 Dwyer, Jr. Oct 1968 A
3573069 Keller et al. Mar 1971 A
3608709 Pike Sep 1971 A
3635376 Hellstrom Jan 1972 A
3921805 Compere Nov 1975 A
4275840 Staar Jun 1981 A
4294361 Margulies et al. Oct 1981 A
4301923 Vuorento Nov 1981 A
4402402 Pike Sep 1983 A
4511052 Klein et al. Apr 1985 A
D279808 Pharo Jul 1985 S
4540089 Maloney Sep 1985 A
4597244 Pharo Jul 1986 A
4610684 Knox et al. Sep 1986 A
4632244 Landau Dec 1986 A
4704314 Hsu et al. Nov 1987 A
4711359 White et al. Dec 1987 A
4759472 Strenger Jul 1988 A
4793123 Pharo Dec 1988 A
4798288 Holzner Jan 1989 A
4872556 Farmer Oct 1989 A
4872558 Pharo Oct 1989 A
4874093 Pharo Oct 1989 A
4890744 Lane, Jr. et al. Jan 1990 A
4918904 Pharo Apr 1990 A
4949530 Pharo Aug 1990 A
4961495 Yoshida et al. Oct 1990 A
5009894 Hsiao Apr 1991 A
5050736 Griesbach Sep 1991 A
5100028 Siefert Mar 1992 A
5114004 Isono et al. May 1992 A
5126070 Leifheit et al. Jun 1992 A
5207320 Allen May 1993 A
5215221 Dirksing Jun 1993 A
5272856 Pharo Dec 1993 A
5325968 Sowden Jul 1994 A
5373966 O'Reilly et al. Dec 1994 A
5427830 Pharo Jun 1995 A
5445274 Pharo Aug 1995 A
5447235 Pharo Sep 1995 A
5487470 Pharo Jan 1996 A
5492219 Stupar Feb 1996 A
5588532 Pharo Dec 1996 A
D386074 Pharo Nov 1997 S
5711691 Damask et al. Jan 1998 A
5775491 Taniyama Jul 1998 A
5792213 Bowen Aug 1998 A
5814159 Paley et al. Sep 1998 A
5865309 Futagawa et al. Feb 1999 A
5870884 Pike Feb 1999 A
5910138 Sperko et al. Jun 1999 A
5928213 Barney et al. Jul 1999 A
5944709 Barney et al. Aug 1999 A
5957358 Getz et al. Sep 1999 A
5967308 Bowen Oct 1999 A
6001187 Paley et al. Dec 1999 A
6007264 Koptis Dec 1999 A
6036004 Bowen Mar 2000 A
6068820 De Guzman May 2000 A
6165161 York et al. Dec 2000 A
6198106 Barney et al. Mar 2001 B1
6203535 Barney et al. Mar 2001 B1
6468377 Sperko et al. Oct 2002 B1
6491159 Shibata Dec 2002 B2
6547468 Gruenbacher et al. Apr 2003 B2
6726364 Perell Apr 2004 B2
6773163 Ichikawa et al. Aug 2004 B2
6846305 Smith et al. Jan 2005 B2
6935492 Loeb Aug 2005 B1
6968952 Crevier et al. Nov 2005 B2
6974032 Intini Dec 2005 B2
6996951 Smith et al. Feb 2006 B2
7051879 Ramet May 2006 B2
7055683 Bourque et al. Jun 2006 B2
7175614 Gollier et al. Feb 2007 B2
7306095 Bourque et al. Dec 2007 B1
20020150658 Morrissette et al. Oct 2002 A1
20020170832 Klair Nov 2002 A1
20030019781 Kocher Jan 2003 A1
20030075561 Pieri Apr 2003 A1
20040057638 Perell et al. Mar 2004 A1
20040226848 Dunn-Rankin Nov 2004 A1
20060023976 Alvater et al. Feb 2006 A1
20060126970 Perell Jun 2006 A1
20070241024 Perell Oct 2007 A1
Foreign Referenced Citations (13)
Number Date Country
2 0314741 Jan 2004 DE
00306207 Mar 1989 EP
00317130 May 1989 EP
2345363 Oct 1977 FR
2253605 Sep 1992 GB
04215927 Aug 1992 JP
11029176 Feb 1999 JP
2000255598 Sep 2000 JP
WO 9623700 Aug 1996 WO
WO 02083504 Oct 2002 WO
WO 2004100856 Nov 2004 WO
2005022323 Mar 2005 WO
WO 2005077811 Aug 2005 WO
Related Publications (1)
Number Date Country
20070235369 A1 Oct 2007 US
Provisional Applications (1)
Number Date Country
60790482 Apr 2006 US